Scpharmaceuticals Inc (SCPH)

May 03, 2025

JPMorgan Chase & Co. Raises Position in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World

May 03, 2025

May 01, 2025

scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences - The Manila Times

May 01, 2025

May 01, 2025

scPharmaceuticals Expands Investor Outreach: CEO Set for Citizens, Craig-Hallum, and Wainwright Conferences - Stock Titan

May 01, 2025

Apr 29, 2025

Geode Capital Management LLC Boosts Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World

Apr 29, 2025

Apr 28, 2025

Stock Market Recap: scPharmaceuticals Inc (SCPH) Concludes at 2.63, a -5.23 Surge/Decline - DWinneX

Apr 28, 2025

Apr 27, 2025

Purple Biotech (NASDAQ:PPBT) versus scPharmaceuticals (NASDAQ:SCPH) Financial Review - Defense World

Apr 27, 2025

Apr 16, 2025

Corebridge Financial Inc. Raises Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World

Apr 16, 2025

Apr 10, 2025

Raymond James Financial Inc. Makes New $318,000 Investment in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World

Apr 10, 2025

Apr 07, 2025

SCPH stock touches 52-week low at $2.19 amid market challenges - Investing.com

Apr 07, 2025

Apr 06, 2025

U.S. FDA approves ScPharmaceuticals' heart failure therapy - MarketScreener

Apr 06, 2025

Apr 04, 2025

Market Cool On scPharmaceuticals Inc.'s (NASDAQ:SCPH) Revenues Pushing Shares 30% Lower - simplywall.st

Apr 04, 2025

Apr 02, 2025

Charles Schwab Investment Management Inc. Acquires 26,964 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World

Apr 02, 2025

Mar 30, 2025

Bank of New York Mellon Corp Raises Stock Position in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World

Mar 30, 2025

Mar 28, 2025

scPharmaceuticals stock hits 52-week low at $2.73 By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

scPharmaceuticals stock hits 52-week low at $2.73 - Investing.com India

Mar 28, 2025

Mar 23, 2025

Maxim Group Cuts scPharmaceuticals (NASDAQ:SCPH) Price Target to $12.00 - Defense World

Mar 23, 2025

Mar 22, 2025

scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 22, 2025

Mar 21, 2025

scPharmaceuticals Inc (SCPH) Q4 2024 Earnings Report Preview: Wh - GuruFocus

Mar 21, 2025

Mar 21, 2025

ScPharmaceuticals outlines FUROSCIX expansion strategy with CKD launch in April 2025 - MSN

Mar 21, 2025

Mar 21, 2025

Optimistic Buy Rating for scPharmaceuticals Amid Strong Q4 Results and Promising Developments - TipRanks

Mar 21, 2025

Mar 21, 2025

scPharmaceuticals Full Year 2024 Earnings: In Line With Expectations - Yahoo Finance

Mar 21, 2025

Mar 20, 2025

Analyst Expectations For scPharmaceuticals's Future - Benzinga

Mar 20, 2025

Mar 20, 2025

Maxim Adjusts Price Target on scPharmaceuticals to $12 From $20, Keeps Buy Rating - Marketscreener.com

Mar 20, 2025

Mar 20, 2025

scPharmaceuticals Inc (SCPH) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance

Mar 20, 2025

Mar 20, 2025

scPharmaceuticals Inc (SCPH) Q4 2024 Earnings Call Highlights: R - GuruFocus

Mar 20, 2025

Mar 19, 2025

scPharmaceuticals Reports Strong Revenue Growth in 2024 - TipRanks

Mar 19, 2025

Mar 19, 2025

Earnings call transcript: SC Pharmaceuticals Q4 2024 beats EPS forecast By Investing.com - Investing.com Australia

Mar 19, 2025

Mar 19, 2025

Earnings call transcript: SC Pharmaceuticals Q4 2024 beats EPS forecast - Investing.com

Mar 19, 2025

Mar 19, 2025

scPharmaceuticals Inc. SEC 10-K Report - TradingView

Mar 19, 2025

Mar 19, 2025

ScPharmaceuticals, Inc. (SCPH) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 19, 2025

Mar 19, 2025

scPharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 19, 2025

Mar 19, 2025

scPharmaceuticals Inc (SCPH) Q4 Earnings: EPS Misses, Revenue Be - GuruFocus

Mar 19, 2025

Mar 19, 2025

SCPHARMACEUTICALS Earnings Results: $SCPH Reports Quarterly Earnings - Nasdaq

Mar 19, 2025

Mar 19, 2025

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView

Mar 19, 2025

Mar 19, 2025

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 19, 2025

Mar 19, 2025

Earnings Scheduled For March 19, 2025 - Benzinga

Mar 19, 2025

Mar 17, 2025

SCPHARMACEUTICALS Earnings Preview: Recent $SCPH Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 17, 2025

Mar 14, 2025

ScPharma Eyes New Frontiers For Furoscix - RTTNews

Mar 14, 2025

Mar 13, 2025

​scPharmaceuticals - The Pharma Letter

Mar 13, 2025

Mar 13, 2025

scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025 - The Manila Times

Mar 13, 2025

Mar 12, 2025

scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, ... - Post Register

Mar 12, 2025

Mar 12, 2025

Breakthroughs in Hyperkalemia DrugsMarket Opportunities - openPR

Mar 12, 2025

Mar 11, 2025

Scpharmaceuticals at Leerink’s Global Healthcare Conference: Strategic Growth Insights By Investing.com - Investing.com Canada

Mar 11, 2025

Mar 11, 2025

scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Acquired by Rhumbline Advisers - Defense World

Mar 11, 2025

Mar 10, 2025

scPharmaceuticals (SCPH) to Release Earnings on Wednesday - Armenian Reporter

Mar 10, 2025

Mar 07, 2025

FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKD - Yahoo

Mar 07, 2025

Mar 07, 2025

H.C. Wainwright maintains Buy on scPharmaceuticals stock, $18 target By Investing.com - Investing.com South Africa

Mar 07, 2025

Mar 07, 2025

H.C. Wainwright maintains Buy on scPharmaceuticals stock, $18 target - Investing.com India

Mar 07, 2025

Mar 07, 2025

Strategic Market Expansion and Strong Sales Foundation Drive Buy Rating for scPharmaceuticals - TipRanks

Mar 07, 2025

Mar 07, 2025

HC Wainwright Cuts Earnings Estimates for scPharmaceuticals - Defense World

Mar 07, 2025

Mar 07, 2025

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease - The Manila Times

Mar 07, 2025

Mar 06, 2025

ScPharmaceuticals Says US FDA Approves Application to Expand Use of Furoscix -March 06, 2025 at 05:42 pm EST - Marketscreener.com

Mar 06, 2025